Benedicte Querton

Benedicte Querton has extensive work experience in various roles related to clinical operations and project management in the pharmaceutical industry. Benedicte currently serves as the Head of Clinical Operations - Early Phase Development at Valneva, where they oversee clinical trial operations. Prior to this, they worked as the Head of Clinical Operations Covid 19 Vaccine at Valneva.

Before joining Valneva, Benedicte founded and owned their own business, House of Q e.U. Benedicte also gained experience in global product operations and network excellence at Shire.

Benedicte's earlier experience includes various roles at Boehringer Ingelheim, where they served as a Group Leader, Regional Clinical Trial Manager, Global/Regional Project Lead/Manager, and TMF Governance Committee Member. Benedicte played a key role in implementing change management and optimizing trial documentation processes.

Benedicte also has experience as the Head of Central Lab at ABF Pharmaceutical Services, where they set up central lab services and implemented new processes and services. Prior to that, Benedicte worked as a Clinical Project Manager at Assign Group and Intercell AG (now Valneva), managing and coordinating international clinical trials.

In addition to their experience in the pharmaceutical industry, Benedicte has worked in business development and clinical project management at B&C Group, providing packaging and logistics services for clinical research. Benedicte also worked at the European Commission in the Office for Infrastructure and Logistics.

Overall, Benedicte Querton has a diverse background in clinical operations, project management, change management, and business development in the pharmaceutical industry.

Benedicte Querton completed their European Baccalaureat in Sciences with a focus on Biology, Chemistry, and Physics at the European School of Brussels from 1987 to 1999. Benedicte then pursued an Engineer degree in Chemistry and Bio-Industries at the Université libre de Bruxelles from 1999 to 2004.